Firms

TNBT Capital

TNBT Capital

Paris, France

tnbtcapital.com

TNBT Capital is a French family office and company-building investor led by Robert Picarel. Its current own legal notice identifies TNBT CAPITAL SAS, Paris RCS/SIREN887642593, at128 rue La Boétie,75008Paris. The French government's active-company registry gives legal creation July24,2020; the firm's own founder narrative describes the family-office investment activity as founded in2021. These are distinct legal and operating milestones. Its published model combines company creation, operational support, acquisitions, venture investing and private debt across healthcare, medical technologies and infrastructure. The own portfolio identifies adaptive brain-stimulation developer Newronika and stroke-device developer Anaconda Biomed, alongside Spiral Therapeutics, Askel Healthcare, ARTHA and other named projects. Newronika's February13,2025 primary issuer announcement identifies TNBT as an existing investor participating in its completed EUR13.6M SeriesB; TNBT's ticket and legal subscribing account are not public. Current own materials publish founder Robert Picarel but no comprehensive operating-staff directory. The legal notice's EUR18,007,357 corporate share capital is not an external LP fund close or cash raised; no publicly verified LP vehicle, closed fund size or investment allocation is invented. Current portfolio entries establish named relationships, not financing dates, product approvals or clinical efficacy.

Founded
2020
Type
Venture capital

Funds0

No funds on record yet.

Team

Operations and support

Robert PicarelRobert PicarelFounder and President

Co-investing

Investments